In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
A-56619 and A-56620 are two new aryl-fluoroquinolones which are as potent as or more potent than norfloxacin when administered orally and subcutaneously in mouse protection tests against Staphylococcus aureus, Streptococcus pyogenes, and Streptococcus pneumoniae. A-56619 and A-56620 were more potent...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1986
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC176377/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3521473/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.29.2.201 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|